These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20578155)

  • 1. Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease.
    Yilmaz Y; Yonal O; Kurt R; Avsar E
    Hepatology; 2010 Jul; 52(1):391; author reply 391-2. PubMed ID: 20578155
    [No Abstract]   [Full Text] [Related]  

  • 2. Smoking is associated with histological severity in nonalcoholic steatohepatitis.
    Tsochatzis EA; Papatheodoridis GV
    Hepatology; 2010 Oct; 52(4):1522-3. PubMed ID: 20814892
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.
    Wieckowska A; Zein NN; Yerian LM; Lopez AR; McCullough AJ; Feldstein AE
    Hepatology; 2006 Jul; 44(1):27-33. PubMed ID: 16799979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
    Nayak NC; Vasdev N; Saigal S; Soin AS
    Hum Pathol; 2010 Mar; 41(3):425-30. PubMed ID: 19954815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
    Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression, anxiety, and nonalcoholic steatohepatitis.
    Elwing JE; Lustman PJ; Wang HL; Clouse RE
    Psychosom Med; 2006; 68(4):563-9. PubMed ID: 16868265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
    Akyol G; Erdem O; Yilmaz G
    Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
    Miyaaki H; Ichikawa T; Nakao K; Yatsuhashi H; Furukawa R; Ohba K; Omagari K; Kusumoto Y; Yanagi K; Inoue O; Kinoshita N; Ishibashi H; Yano M; Eguchi K
    Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA; Torgerson S; Hayashi PH
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cigarette smoking an independent risk factor or a cofactor for nonalcoholic fatty liver disease?
    Xu CF; Yu CH; Xu L; Miao M; Li YM
    Hepatology; 2010 Aug; 52(2):803-4. PubMed ID: 20683979
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease.
    Targher G
    J Hepatol; 2006 Dec; 45(6):879-81; author reply 881-2. PubMed ID: 17049665
    [No Abstract]   [Full Text] [Related]  

  • 15. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.
    Mendler MH; Kanel G; Govindarajan S
    Liver Int; 2005 Apr; 25(2):294-304. PubMed ID: 15780053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.
    Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M
    Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity.
    Ballestri S; Day CP; Daly AK
    Gastroenterology; 2011 May; 140(5):1694-5. PubMed ID: 21439984
    [No Abstract]   [Full Text] [Related]  

  • 18. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
    Adams LA; Sanderson S; Lindor KD; Angulo P
    J Hepatol; 2005 Jan; 42(1):132-8. PubMed ID: 15629518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.
    Bookman ID; Pham J; Guindi M; Heathcote EJ
    Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history?
    Ong JP; Younossi ZM
    Am J Gastroenterol; 2003 Sep; 98(9):1915-7. PubMed ID: 14499766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.